220 related articles for article (PubMed ID: 36499305)
1. Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival.
Ye Q; Hickey J; Summers K; Falatovich B; Gencheva M; Eubank TD; Ivanov AV; Guo NL
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499305
[TBL] [Abstract][Full Text] [Related]
2. A Multi-Omics Network of a Seven-Gene Prognostic Signature for Non-Small Cell Lung Cancer.
Ye Q; Falatovich B; Singh S; Ivanov AV; Eubank TD; Guo NL
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008645
[TBL] [Abstract][Full Text] [Related]
3. Hub Genes in Non-Small Cell Lung Cancer Regulatory Networks.
Ye Q; Guo NL
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551208
[TBL] [Abstract][Full Text] [Related]
4. Molecular Analysis of
Ye Q; Mohamed R; Dakhlallah D; Gencheva M; Hu G; Pearce MC; Kolluri SK; Marsh CB; Eubank TD; Ivanov AV; Guo NL
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916522
[TBL] [Abstract][Full Text] [Related]
5. Immune-Omics Networks of
Ye Q; Singh S; Qian PR; Guo NL
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503105
[TBL] [Abstract][Full Text] [Related]
6. Identification of a potential tumor suppressor gene,
Zhao X; Yongchun Z; Qian H; Sanhui G; Jie L; Hong Y; Yanfei Z; Guizhen W; Yunchao H; Guangbiao Z
Cancer Biol Med; 2020 Feb; 17(1):76-87. PubMed ID: 32296577
[No Abstract] [Full Text] [Related]
7. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
8. Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data.
Ye Q; Putila J; Raese R; Dong C; Qian Y; Dowlati A; Guo NL
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299277
[TBL] [Abstract][Full Text] [Related]
9. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer.
Zhou M; Chen Y; Gu X; Wang C
Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144
[No Abstract] [Full Text] [Related]
11. TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancer.
Zhang T; Liu C; Yu Y; Geng J; Meng Q; Xu S; Zhou F; Chen Y; Jin S; Shen J; Pan B; Meng F; Liu F
Cancer Gene Ther; 2020 Apr; 27(3-4):136-146. PubMed ID: 31243347
[TBL] [Abstract][Full Text] [Related]
12. Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer.
Agulló-Ortuño MT; Díaz-García CV; Agudo-López A; Pérez C; Cortijo A; Paz-Ares L; López-Ríos F; Pozo F; de Castro J; Cortés-Funes H; López Martín JA
J Cancer Res Clin Oncol; 2015 Jan; 141(1):43-53. PubMed ID: 25081930
[TBL] [Abstract][Full Text] [Related]
13. Gene co-expression modules integrated with immunoscore predicts survival of non-small cell lung cancer.
Li XT; Zhang JT; Yan HH; Su J; Cheng ML; Sun QH; Zhong WZ; Wu YL; Zhang DX; Hou DJ
Cancer Treat Res Commun; 2021; 26():100297. PubMed ID: 33385734
[TBL] [Abstract][Full Text] [Related]
14. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.
Redin E; Garmendia I; Lozano T; Serrano D; Senent Y; Redrado M; Villalba M; De Andrea CE; Exposito F; Ajona D; Ortiz-Espinosa S; Remirez A; Bertolo C; Sainz C; Garcia-Pedrero J; Pio R; Lasarte J; Agorreta J; Montuenga LM; Calvo A
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33658304
[TBL] [Abstract][Full Text] [Related]
15. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
16. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
17. Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects.
Zhang R; Chen C; Dong X; Shen S; Lai L; He J; You D; Lin L; Zhu Y; Huang H; Chen J; Wei L; Chen X; Li Y; Guo Y; Duan W; Liu L; Su L; Shafer A; Fleischer T; Moksnes Bjaanæs M; Karlsson A; Planck M; Wang R; Staaf J; Helland Å; Esteller M; Wei Y; Chen F; Christiani DC
Chest; 2020 Aug; 158(2):808-819. PubMed ID: 32113923
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells.
Du Z; Wu J; Wang J; Liang Y; Zhang S; Shang Z; Zuo W
Diagn Pathol; 2019 Dec; 14(1):132. PubMed ID: 31801557
[TBL] [Abstract][Full Text] [Related]
19.
Yaegashi LB; Baldavira CM; Prieto TG; Machado-Rugolo J; Velosa APP; da Silveira LKR; Assato A; Ab'Saber AM; Falzoni R; Takagaki T; Silva PL; Teodoro WR; Capelozzi VL
Front Immunol; 2021; 12():714230. PubMed ID: 34484217
[TBL] [Abstract][Full Text] [Related]
20. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]